Sign in

CIK 0001372514 · Non-accelerated filer<br>Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980443284
Phone
858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
  1. 4 Grant or award President and CEO acquired 15,941 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 1,250 shares at $3.68 ($4,600)
  9. 4 Open-market buy Director bought 3,000 shares at $3.60 ($10,800)
  10. 4 Open-market buy Director bought 1,250 shares at $3.86 ($4,825)
  11. 4 Open-market buy Director bought 5,000 shares at $3.96 ($19,800)
  12. 4 Open-market buy CFO bought 2,000 shares at $3.21 ($6,420)
  13. 4 Grant or award President and CEO acquired 15,629 shares (grant or award)
  14. 4 Grant or award CFO acquired 7,620 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Development Officer acquired 7,355 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 21 · 406 filings